Author

Nawaid Usmani

Observed name: Usmani, Nawaid

Institutions: University of Alberta, Cross Cancer Institute

Observed institutions: University of Alberta, Manchester Academic Health Science Centre, University of Manchester, Complejo Hospitalario Universitario de Santiago, Fundación Pública Galega de Medicina Xenómica, Health Innovation Manchester, Instituto de Investigación Sanitaria de Santiago, Servicio Gallego de Salud, NIHR Manchester Biomedical Research Centre, Moores Cancer Center, Cancer Research UK Manchester Centre, Cross Cancer Institute, KU Leuven

OpenAlex ID: A5107334266

Association between circulating inflammatory markers and adult cancer risk: a Mendelian randomization analysis

2024 · James Yarmolinsky, Jamie W. Robinson, et al. · EBioMedicine · 53

Evaluating approaches for constructing polygenic risk scores for prostate cancer in men of African and European ancestry

2023 · Burcu F. Darst, Jiayi Shen, et al. · The American Journal of Human Genetics · 28

A PSA SNP associates with cellular function and clinical outcome in men with prostate cancer

2024 · Srilakshmi Srinivasan, Thomas Kryza, et al. · Nature Communications · 16

2021 Canadian Urological Association (CUA)-Canadian Uro Oncology Group (CUOG) guideline: Management of castration-resistant prostate cancer (CRPC).

2021 · Fred Saad, Armen Aprikian, et al. · PubMed · 14

Observational and genetic associations between cardiorespiratory fitness and cancer: a UK Biobank and international consortia study

2023 · Eleanor L. Watts, Tomas I. Gonzales, et al. · British Journal of Cancer · 9

Genomic risk model to implement precision prostate cancer screening in clinical care: the ProGRESS study

2026 · Jason L. Vassy, Anna M. Dornisch, et al. · Nature Cancer · 7

Polygenic risk score with KLK3 SNP-SNP interaction pairs for predicting prostate cancer aggressiveness

2026 · Hui-Yi Lin, Indrani Sarkar, et al. · Communications Medicine

Germline polygenic score for prostate cancer aggressiveness

2026 · George Xu, Roshan Karunamuni, et al. · medRxiv

Combining External Beam Radiotherapy and Immunotherapy for the Treatment of Hepatocellular Carcinoma

2026 · Connie Le, Aswin G. Abraham, et al. · Current Oncology

Metformin modifies hormone changes associated with androgen deprivation therapy for prostate cancer

2026 · Mathew Gorman, Nawaid Usmani, et al. · Endocrine Oncology

18 F‐PSMA‐1007 PET/CT Demonstrates Higher Accuracy for Biochemically Recurrent Prostate Cancer Compared to Contemporary Conventional Imaging

2026 · Zachary Stanton, Bonnie Woloschuk, et al. · Advances in Urology

Standard of Care and Psma-pet-based Patterns of Radiotherapy for Prostate Cancer in a Pan-canadian Phase 3 Randomized Controlled Trial (patron)

2025 · Sympascho Young, Cynthia Ménard, et al. · Radiotherapy and Oncology

Works count: 14

Citation count: 127

H-index: 6

I10-index: 4